DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Reactor production of Thorium-229

Abstract

Limited availability of 229Th for clinical applications of 213Bi necessitates investigation of alternative production routes. In reactor production, 229Th is produced from neutron transmutation of 226Ra, 228Ra, 227Ac and 228Th. Here, we evaluate irradiations of 226Ra, 228Ra, and 227Ac targets at the ORNL High Flux Isotope Reactor.

Authors:
 [1];  [1];  [1]; ;  [1];  [1];  [1];  [1]
  1. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
Publication Date:
Research Org.:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
Sponsoring Org.:
USDOE Office of Nuclear Energy (NE)
OSTI Identifier:
1253240
Alternate Identifier(s):
OSTI ID: 1358796
Grant/Contract Number:  
AC05-00OR22725
Resource Type:
Accepted Manuscript
Journal Name:
Applied Radiation and Isotopes
Additional Journal Information:
Journal Volume: 114; Journal Issue: C; Journal ID: ISSN 0969-8043
Publisher:
Elsevier
Country of Publication:
United States
Language:
English
Subject:
22 GENERAL STUDIES OF NUCLEAR REACTORS; Thorium-229; Thorium-228; Actinium-225; Actinium-227; Radium-226; Radium-228; neutron reactions; isochain; high flux isotope reactor

Citation Formats

Boll, Rose Ann, Murphy, Karen E., Denton, David L., Tamara J. Haverlock, Garland, Marc A., Mirzadeh, Saed, Hogle, Susan, and Owens, Allison. Reactor production of Thorium-229. United States: N. p., 2016. Web. doi:10.1016/j.apradiso.2016.05.002.
Boll, Rose Ann, Murphy, Karen E., Denton, David L., Tamara J. Haverlock, Garland, Marc A., Mirzadeh, Saed, Hogle, Susan, & Owens, Allison. Reactor production of Thorium-229. United States. https://doi.org/10.1016/j.apradiso.2016.05.002
Boll, Rose Ann, Murphy, Karen E., Denton, David L., Tamara J. Haverlock, Garland, Marc A., Mirzadeh, Saed, Hogle, Susan, and Owens, Allison. Tue . "Reactor production of Thorium-229". United States. https://doi.org/10.1016/j.apradiso.2016.05.002. https://www.osti.gov/servlets/purl/1253240.
@article{osti_1253240,
title = {Reactor production of Thorium-229},
author = {Boll, Rose Ann and Murphy, Karen E. and Denton, David L. and Tamara J. Haverlock and Garland, Marc A. and Mirzadeh, Saed and Hogle, Susan and Owens, Allison},
abstractNote = {Limited availability of 229Th for clinical applications of 213Bi necessitates investigation of alternative production routes. In reactor production, 229Th is produced from neutron transmutation of 226Ra, 228Ra, 227Ac and 228Th. Here, we evaluate irradiations of 226Ra, 228Ra, and 227Ac targets at the ORNL High Flux Isotope Reactor.},
doi = {10.1016/j.apradiso.2016.05.002},
journal = {Applied Radiation and Isotopes},
number = C,
volume = 114,
place = {United States},
year = {Tue May 03 00:00:00 EDT 2016},
month = {Tue May 03 00:00:00 EDT 2016}
}

Journal Article:

Citation Metrics:
Cited by: 20 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Cyclotron production of Ac-225 for targeted alpha therapy11Dedicated to Prof. Dr. Franz Baumgärtner on the occasion of his 75th birthday.
journal, March 2005


Production of Ac-225 from Th-229 for Targeted α Therapy
journal, October 2005

  • Apostolidis, C.; Molinet, R.; Rasmussen, G.
  • Analytical Chemistry, Vol. 77, Issue 19
  • DOI: 10.1021/ac0580114

Production of actinium-225 for alpha particle mediated radioimmunotherapy
journal, May 2005


Reactor Production of Thorium-229
conference, January 2005

  • Boll, Rose A.
  • INTERNATIONAL CONFERENCE ON NUCLEAR DATA FOR SCIENCE AND TECHNOLOGY, AIP Conference Proceedings
  • DOI: 10.1063/1.1945330

New Treatment Option: 223Ra Chloride, the First Approved Unsealed α-Emitting Radiopharmaceutical
journal, January 2013


Thorium-229 for Medical Applications
book, November 2003


Measurement of cross sections for the [sup 232]Th(P,4n)[sup 229]Pa reaction at low proton energies
conference, January 2013

  • Jost, C. U.; Griswold, J. R.; Bruffey, S. H.
  • APPLICATION OF ACCELERATORS IN RESEARCH AND INDUSTRY: Twenty-Second International Conference, AIP Conference Proceedings
  • DOI: 10.1063/1.4802383

An overview of targeted alpha therapy
journal, December 2011


Yields of activation products in 226Ra irradiation in the high-flux SM reactor
journal, July 2012


Neutron dosimetry of the HFIR hydraulic facility
report, February 1995


Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
journal, September 2008

  • Miederer, Matthias; Scheinberg, David A.; McDevitt, Michael R.
  • Advanced Drug Delivery Reviews, Vol. 60, Issue 12
  • DOI: 10.1016/j.addr.2008.04.009

Generator-produced alpha-emitters
journal, April 1998


Decay of 37.5-min Th 236 and 9.1-min Pa 236
journal, March 1984


Decay of 7.3-min Th 235 and 24.6-min Pa 235
journal, June 1986


Numerical evaluation of the production of radionuclides in a nuclear reactor (Part II)
journal, April 1998


225Ac and 223Ra production via 800MeV proton irradiation of natural thorium targets
journal, November 2012


Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200MeV
journal, November 2012


Production of 225Ac and 223Ra by irradiation of Th with accelerated protons
journal, February 2011


Works referencing / citing this record:

Development of 225 Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences
journal, October 2018

  • Robertson, Andrew Kyle Henderson; Ramogida, Caterina Fortunata; Schaffer, Paul
  • Current Radiopharmaceuticals, Vol. 11, Issue 3
  • DOI: 10.2174/1874471011666180416161908